Manulife (Manufacturers Life Insurance)
PRAX icon

Manulife (Manufacturers Life Insurance)’s Praxis Precision Medicines PRAX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.7M Sell
30,093
-3,198
-10% -$989K 0.01% 863
2025
Q4 		$9.86M Sell
33,291
-2,538
-7% -$473K 0.01% 879
2025
Q3 		$1.9M Sell
35,829
-20,302
-36% -$984K ﹤0.01% 1539
2025
Q2 		$2.36M Buy
56,131
+23,639
+73% +$900K ﹤0.01% 1434
2025
Q1 		$1.23M Sell
32,492
-5,991
-16% -$374K ﹤0.01% 1713
2024
Q4 		$2.96M Buy
38,483
+3,344
+10% +$242K ﹤0.01% 1401
2024
Q3 		$2.02M Sell
35,139
-169
-0.5% -$9.13K ﹤0.01% 1543
2024
Q2 		$1.46M Buy
35,308
+15,443
+78% +$730K ﹤0.01% 1631
2024
Q1 		$1.21M Buy
+19,865
New +$891K ﹤0.01% 1750
2022
Q2 		– Sell
-981
Closed -$150K – 3107
2022
Q1 		$150K Sell
981
-221
-18% -$45.4K ﹤0.01% 2869
2021
Q4 		$355 Buy
1,202
+17
+1% +$4.99K ﹤0.01% 2491
2021
Q3 		$329K Buy
1,185
+215
+22% +$58.3K ﹤0.01% 2592
2021
Q2 		$266K Buy
970
+546
+129% +$196K ﹤0.01% 2906
2021
Q1 		$208K Hold
424
– – ﹤0.01% 2867
2020
Q4 		$350K Buy
+424
New +$247K ﹤0.01% 2415

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s PRAX Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Praxis Precision Medicines (PRAX) stake by 9.6% in Q1 2026, selling an estimated $989K and leaving 30,093 shares worth $9.7M. The position accounts for 0.01% of the portfolio, ranked #863.

Manulife (Manufacturers Life Insurance) first reported a position in PRAX in Q4 2020 and has held it in 15 quarters since. The position peaked at $9.86M in Q4 2025. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 30,093 shares of Praxis Precision Medicines worth $9.7M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 3,198 Praxis Precision Medicines shares in Q1 2026, an estimated $989K.
  • Praxis Precision Medicines made up 0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #863 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 15 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Praxis Precision Medicines position peaked at $9.86M in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.